末梢神経刺激装置の世界市場2021年-2025年

◆英語タイトル:Global Peripheral Nerve Stimulators Market 2021-2025
◆商品コード:IRTNTR70233
◆発行会社(リサーチ会社):Technavio
◆発行日:2021年2月16日
◆ページ数:約120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア、その他の地域
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥285,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥342,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥456,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

テクナビオ社の本調査レポートでは、世界の末梢神経刺激装置市場について調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、製品別(経皮的、埋め込み型)分析、機能別(PNS-TOF、PNS)分析、顧客状況、地域別状況、企業状況、企業分析などの項目を掲載しています。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・世界の末梢神経刺激装置市場規模:製品別(経皮的、埋め込み型)
・世界の末梢神経刺激装置市場規模:機能別(PNS-TOF、PNS)
・顧客状況
・地域別状況
・企業状況
・企業分析
【レポートの概要】

Global Peripheral Nerve Stimulators Market 2021-2025
Technavio has been monitoring the peripheral nerve stimulators market and it is poised to grow by $ 141.03 mn during 2021-2025 progressing at a CAGR of 5% during the forecast period. Our report on peripheral nerve stimulators market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the high demand for peripheral nerve stimulators over oral medications and increasing aging population and rising nerve injury cases. In addition, high demand for peripheral nerve stimulators over oral medications is anticipated to boost the growth of the market as well.
The peripheral nerve stimulators market analysis includes product segment and geographical landscapes.
Technavio’s peripheral nerve stimulators market is segmented as below:

By Product
• Transcutaneous
• Percutaneous
• Implantable

By Type
• PNS-TOF
• PNS

By Geographical Landscapes
• North America
• Europe
• Asia
• ROW

This study identifies the increasing prevalence of neurologic disorders as one of the prime reasons driving the peripheral nerve stimulators market growth during the next few years.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on peripheral nerve stimulators market covers the following areas:
• Peripheral nerve stimulators market sizing
• Peripheral nerve stimulators market forecast
• Peripheral nerve stimulators market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading peripheral nerve stimulators market vendors that include Abbott Laboratories, Avanos Medical Inc., B. Braun Melsungen AG, Bioness Inc., Boston Scientific Corp., Medtronic Plc, PAJUNK GmbH Medical Technology, SPR Therapeutics Inc., SunMed LLC, and Xavant Technology Pty Ltd.. Also, the peripheral nerve stimulators market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/peripheral-nerve-stimulators-market-industry-analysis

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

【レポートの目次】

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2020
o Market outlook: Forecast for 2020 – 2025
• Five Forces Analysis
o Five forces summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Product
o Market segments
o Comparison by Product
o Transcutaneous – Market size and forecast 2020-2025
o Percutaneous – Market size and forecast 2020-2025
o Implantable – Market size and forecast 2020-2025
o Market opportunity by Product
• Market Segmentation by Stimulating Feature
o Market segments
o Comparison by Stimulating Feature
o PNS-TOF – Market size and forecast 2020-2025
o PNS – Market size and forecast 2020-2025
o Market opportunity by Stimulating Feature
• Customer landscape
o Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2020-2025
o Europe – Market size and forecast 2020-2025
o Asia – Market size and forecast 2020-2025
o ROW – Market size and forecast 2020-2025
o Key leading countries
o Market opportunity by geography
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Abbott Laboratories
o Avanos Medical Inc.
o B. Braun Melsungen AG
o Bioness Inc.
o Boston Scientific Corp.
o Medtronic Plc
o PAJUNK GmbH Medical Technology
o SPR Therapeutics Inc.
o SunMed LLC
o Xavant Technology Pty Ltd.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Key Finding 9
• 9: Parent market
• 10: Market characteristics
• 11: Offerings of vendors included in the market definition
• 12: Market segments
• 13: Global – Market size and forecast 2020 – 2025 ($ million)
• 14: Global market: Year-over-year growth 2020 – 2025 (%)
• 15: Five forces analysis 2020 & 2025
• 16: Bargaining power of buyers
• 17: Bargaining power of suppliers
• 18: Threat of new entrants
• 19: Threat of substitutes
• 20: Threat of rivalry
• 21: Market condition – Five forces 2020
• 22: Product – Market share 2020-2025 (%)
• 23: Comparison by Product
• 24: Transcutaneous – Market size and forecast 2020-2025 ($ million)
• 25: Transcutaneous – Year-over-year growth 2020-2025 (%)
• 26: Percutaneous – Market size and forecast 2020-2025 ($ million)
• 27: Percutaneous – Year-over-year growth 2020-2025 (%)
• 28: Implantable – Market size and forecast 2020-2025 ($ million)
• 29: Implantable – Year-over-year growth 2020-2025 (%)
• 30: Market opportunity by Product
• 31: Other1 – Market share 2020-2025 (%)
• 32: Comparison by Other1
• 33: PNS-TOF – Market size and forecast 2020-2025 ($ million)
• 34: PNS-TOF – Year-over-year growth 2020-2025 (%)
• 35: PNS – Market size and forecast 2020-2025 ($ million)
• 36: PNS – Year-over-year growth 2020-2025 (%)
• 37: Market opportunity by Other1
• 38: Customer landscape
• 39: Market share by geography 2020-2025 (%)
• 40: Geographic comparison
• 41: North America – Market size and forecast 2020-2025 ($ million)
• 42: North America – Year-over-year growth 2020-2025 (%)
• 43: Europe – Market size and forecast 2020-2025 ($ million)
• 44: Europe – Year-over-year growth 2020-2025 (%)
• 45: Asia – Market size and forecast 2020-2025 ($ million)
• 46: Asia – Year-over-year growth 2020-2025 (%)
• 47: ROW – Market size and forecast 2020-2025 ($ million)
• 48: ROW – Year-over-year growth 2020-2025 (%)
• 49: Key leading countries
• 50: Market opportunity by geography ($ million)
• 51: Impact of drivers and challenges
• 52: Vendor landscape
• 53: Landscape disruption
• 54: Industry risks
• 55: Vendors covered
• 56: Market positioning of vendors
• 57: Abbott Laboratories – Overview
• 58: Abbott Laboratories – Business segments
• 59: Abbott Laboratories – Key offerings
• 60: Abbott Laboratories – Key customers
• 61: Abbott Laboratories – Segment focus
• 62: Avanos Medical Inc. – Overview
• 63: Avanos Medical Inc. – Business segments
• 64: Avanos Medical Inc. – Key offerings
• 65: Avanos Medical Inc. – Key customers
• 66: Avanos Medical Inc. – Segment focus
• 67: B. Braun Melsungen AG – Overview
• 68: B. Braun Melsungen AG – Business segments
• 69: B. Braun Melsungen AG – Key offerings
• 70: B. Braun Melsungen AG – Key customers
• 71: B. Braun Melsungen AG – Segment focus
• 72: Bioness Inc. – Overview
• 73: Bioness Inc. – Product and service
• 74: Bioness Inc. – Key offerings
• 75: Bioness Inc. – Key customers
• 76: Bioness Inc. – Segment focus
• 77: Boston Scientific Corp. – Overview
• 78: Boston Scientific Corp. – Business segments
• 79: Boston Scientific Corp. – Key offerings
• 80: Boston Scientific Corp. – Key customers
• 81: Boston Scientific Corp. – Segment focus
• 82: Medtronic Plc – Overview
• 83: Medtronic Plc – Business segments
• 84: Medtronic Plc – Key offerings
• 85: Medtronic Plc – Key customers
• 86: Medtronic Plc – Segment focus
• 87: PAJUNK GmbH Medical Technology – Overview
• 88: PAJUNK GmbH Medical Technology – Product and service
• 89: PAJUNK GmbH Medical Technology – Key offerings
• 90: PAJUNK GmbH Medical Technology – Key customers
• 91: PAJUNK GmbH Medical Technology – Segment focus
• 92: SPR Therapeutics Inc. – Overview
• 93: SPR Therapeutics Inc. – Product and service
• 94: SPR Therapeutics Inc. – Key offerings
• 95: SPR Therapeutics Inc. – Key customers
• 96: SPR Therapeutics Inc. – Segment focus
• 97: SunMed LLC – Overview
• 98: SunMed LLC – Product and service
• 99: SunMed LLC – Key offerings
• 100: SunMed LLC – Key customers
• 101: SunMed LLC – Segment focus
• 102: Xavant Technology Pty Ltd. – Overview
• 103: Xavant Technology Pty Ltd. – Product and service
• 104: Xavant Technology Pty Ltd. – Key offerings
• 105: Xavant Technology Pty Ltd. – Key customers
• 106: Xavant Technology Pty Ltd. – Segment focus
• 107: Currency conversion rates for US$
• 108: Research Methodology
• 109: Validation techniques employed for market sizing
• 110: Information sources
• 111: List of abbreviations



【掲載企業】

Abbott Laboratories, Avanos Medical Inc., B. Braun Melsungen AG, Bioness Inc., Boston Scientific Corp., Medtronic Plc, PAJUNK GmbH Medical Technology, SPR Therapeutics Inc., SunMed LLC, Xavant Technology Pty Ltd.

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[末梢神経刺激装置の世界市場2021年-2025年]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆